SCHEMBL1723739

SCHEMBL1723739

CC(=O)N1CCN(c2ccc(CSC3COC(Cn4cncn4)(c4ccc(F)cc4F)O3)cc2)CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 18/20 0.42
▸ CYP19A1 P11511 5/20 0.42
▸ CYP17A1 P05093 4/20 0.42
▸ ABCG2 Q9UNQ0 4/20 0.42
▸ CYP11B1 P15538 3/20 0.42
▸ ABCB11 O95342 3/20 0.42
▸ CYP8B1 Q9UNU6 3/20 0.42
▸ CYP2C9 P11712 2/20 0.42
▸ CYP11B2 P19099 2/20 0.42
▸ PTGS2 P35354 1/20 0.42
▸ LMNA P02545 3/20 0.41
▸ CYP51A1 Q16850 3/20 0.41
▸ NR1I2 O75469 2/20 0.41
▸ HSP90AA1 P07900 2/20 0.41
▸ CHRM2 P08172 2/20 0.41
▸ ADRA2A P08913 2/20 0.41
▸ TSHR P16473 2/20 0.41
▸ ADRA2B P18089 2/20 0.41
▸ SLC6A2 P23975 2/20 0.41
▸ HTR2A P28223 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1722997 0.86 CYP3A4 (0.42) CYP3A4CYP19A1CYP17A1ABCG2CYP11B1
SCHEMBL3398153 0.86 CYP3A4 (0.54) CYP3A4CYP19A1CYP17A1ABCG2CYP11B1
SCHEMBL3338267 0.86 CYP3A4 (0.48) CYP3A4CYP19A1CYP17A1ABCG2CYP11B1
SCHEMBL1723630 0.85 ABCG2 (0.58) CYP3A4CYP19A1CYP17A1ABCG2CYP11B1
SCHEMBL1724096 0.84 CYP3A4 (0.46) CYP3A4CYP19A1CYP17A1ABCG2CYP11B1
SCHEMBL1723455 0.84 CYP3A4 (0.51) CYP3A4CYP19A1CYP17A1ABCG2CYP11B1
SCHEMBL1723544 0.83 CYP3A4 (0.51) CYP3A4CYP19A1CYP17A1ABCG2CYP11B1
SCHEMBL1723143 0.75 CYP3A4 (0.37) CYP3A4CYP19A1CYP17A1ABCG2CYP11B1
SCHEMBL1722926 0.74 CYP3A4 (0.46) CYP3A4CYP19A1CYP17A1ABCG2CYP11B1
SCHEMBL9251680 0.73 CYP3A4 (0.55) CYP3A4CYP19A1CYP17A1ABCG2CYP11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2343980-A1 TRIAZOLE ANTIFUNGAL AGENTS Wu, Nian (US) 2011-07-20 — — EP disclosed
US-20100143455-A1 Triazole antifungal agents WU NIAN 2010-06-10 — — US disclosed
US-20100143455-A1 Triazole antifungal agents WU NIAN 2010-06-10 — — US disclosed
US-20100143455-A1 Triazole antifungal agents WU NIAN 2010-06-10 — — US disclosed
WO-2010027496-A1 TRIAZOLE ANTIFUNGAL AGENTS WU NIAN (US) 2010-03-11 — — WO disclosed
WO-2010027496-A1 TRIAZOLE ANTIFUNGAL AGENTS WU NIAN (US) 2010-03-11 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100143455-A1 Triazole antifungal agents CYP3A7, ERG28, UGT1A7 CYP3A4 33/4885CYP19A1 1855/4885CYP17A1 2137/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback